BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1202@pharmaconomics
DTSTAMP:20260707T010022Z
DTSTART;VALUE=DATE:20260911
DTEND;VALUE=DATE:20260912
SUMMARY:TLX PDUFA — TLX101-Px
DESCRIPTION:The FDA's approval decision on TLX101-Px for glioma is due Sep 11\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/2007191/000162828026023982/q1businessupdate.htm\n\nTrack it: https://www.pharmaconomics.com/e/1202
URL:https://www.pharmaconomics.com/e/1202
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TLX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR